Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor Accentuates CD47 Blockade Therapy Resulting in Long Term Survival in Acute Myeloid Leukemia
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:3322-3323 - Subject
- Language
- ISSN
- 0006-4971